WINTON GROUP Ltd Cuts Position in Maximus, Inc. $MMS

WINTON GROUP Ltd cut its stake in Maximus, Inc. (NYSE:MMS) by 49.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 34,404 shares of the health services provider’s stock after selling 33,541 shares during the quarter. WINTON GROUP Ltd owned about 0.06% of Maximus worth $2,970,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Maximus by 19.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock worth $18,304,000 after purchasing an additional 33,136 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after purchasing an additional 36,989 shares in the last quarter. Divisadero Street Capital Management LP boosted its position in shares of Maximus by 93.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock worth $16,800,000 after purchasing an additional 88,872 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Maximus in the 4th quarter worth $15,673,000. Finally, Seizert Capital Partners LLC acquired a new stake in shares of Maximus in the 4th quarter worth $1,863,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 742 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the transaction, the director owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.

Maximus Stock Performance

NYSE MMS opened at $60.49 on Monday. The stock has a 50-day simple moving average of $63.79 and a two-hundred day simple moving average of $76.60. The firm has a market capitalization of $3.18 billion, a P/E ratio of 9.06 and a beta of 0.58. Maximus, Inc. has a fifty-two week low of $56.92 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.Maximus’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, equities analysts forecast that Maximus, Inc. will post 8.43 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.33 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s dividend payout ratio is presently 19.76%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on MMS. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, Maximus has an average rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.